CS logo
small CS logo
St. Mary's Hospital

Kurume, Fukuoka, Japan
Hospital in Kurume
〒830-0047 Fukuoka, Kurume, Tsubukuhonmachi, 422 外来診療棟

About St. Mary's Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Pfizer
4
Bayer
3
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
2
Associations for Establishment of Evidence in Interventions
1
Ferring Pharmaceuticals
1
University Hospital, Lille
1
Total Rows: 6

Clinical Trials at St. Mary's Hospital


During the past decade, St. Mary's Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years22000011110011000000Started TrialsCompleted Trails201720182019202020210123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery
2006-10-01
2016-09-01
Completed
2,025
Long-Term, Open-Label Study Of CP-690,550 For Treatment Of Rheumatoid Arthritis In Japan
2008-04-01
2013-12-01
Completed
487
Japan-Drug Eluting Stents Evaluation; a Randomized Trial
2008-03-01
Completed
3,500
Identifying Prognostic Factors in Patients Receiving Tegafur-Uracil for Stage II Colon Cancer That Was Completely Removed By Surgery
2006-10-01
2016-09-01
Completed
1,111
A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema
2010-05-01
2012-08-01
Completed
243
Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo
2010-07-01
2011-04-01
Completed
116
Pre-stroke Cognitive Status and Thrombolytic Therapy
2011-11-01
2015-03-01
Completed
205
A Study To Evaluate The Safety And Efficacy Of Tofacitinib Modified Release Tablets Compared To Tofacitinib Immediate Release Tablets In Adult Patients With Rheumatoid Arthritis
2014-11-18
2017-03-15
Completed
209

Rows per page:

1–12 of 12

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "St. Mary's Hospital" #1 sponsor was "Pfizer" with 4 trials, followed by "Bayer" with 3 trials sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored, "Associations for Establishment of Evidence in Interventions" with 1 trials sponsored and "Ferring Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "St. Mary's Hospital" #1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator and "Population Health Research Institute" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsPfizer: 4Pfizer: 4Bayer: 3Bayer: 3Translational ResearchCenter for MedicalInnovation, Kobe,Hyogo, Japan: 2Translational ResearchCenter for MedicalInnovation, Kobe,Hyogo, Japan: 2Associations forEstablishment ofEvidence inInterventions: 1Associations forEstablishment ofEvidence inInterventions: 1Ferring Pharmaceuticals: 1Ferring Pharmaceuticals: 1University Hospital, Lille: 1University Hospital, Lille: 1

Created with Highcharts 11.1.0Top CollaboratorsTokyo Medical andDental University: 2Tokyo Medical andDental University: 2Population HealthResearch Institute: 1Population HealthResearch Institute: 1

Clinical Trials Conditions at St. Mary's Hospital


According to Clinical.Site data, the most researched conditions in "St. Mary's Hospital" are "Anemia" (2 trials), "Colorectal Cancer" (2 trials), "Renal Insufficiency, Chronic" (2 trials), "Rheumatoid Arthritis" (2 trials) and "Acute Non-cardioembolic Ischemic Stroke" (1 trials). Many other conditions were trialed in "St. Mary's Hospital" in a lesser frequency.

Clinical Trials Intervention Types at St. Mary's Hospital


Most popular intervention types in "St. Mary's Hospital" are "Drug" (10 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Darbepoetin alfa" (2 trials), "Molidustat (BAY85-3934)" (2 trials), "UFT adjuvant chemotherapy" (2 trials), "BAY2433334" (1 trials) and "BAY2433334 matching placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at St. Mary's Hospital


The vast majority of trials in "St. Mary's Hospital" are 12 trials for "All" genders.

Clinical Trials Status at St. Mary's Hospital


Currently, there are NaN active trials in "St. Mary's Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in St. Mary's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in St. Mary's Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 7Phase 3: 7Phase 2: 2Phase 2: 2Not Applicable: 1Not Applicable: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 12Completed: 12